Journal of Ophthalmology

Journal of Ophthalmology / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3926745 | 9 pages | https://doi.org/10.1155/2018/3926745

Analysis of Foveal Microvascular Abnormalities in Diabetic Retinopathy Using Optical Coherence Tomography Angiography with Projection Artifact Removal

Academic Editor: Steven F. Abcouwer
Received18 Apr 2018
Revised11 Jul 2018
Accepted12 Aug 2018
Published18 Sep 2018

Abstract

Purpose. To analyze foveal microvascular abnormalities in different stages of diabetic retinopathy (DR) using optical coherence tomography angiography (OCTA) with projection artifact removal (PAR). Methods. We analyzed 93 eyes of 59 patients with diabetes—31 with no DR (no DR), 34 with mild to moderate nonproliferative DR (mild DR), and 28 with severe nonproliferative DR to proliferative DR (severe DR)—and 31 age-matched healthy controls. Sections measuring 3 × 3 mm2 centered on the fovea were obtained using OCTA. The area, perimeter, and acircularity index (AI) of the foveal avascular zone (FAZ), vessel density within a 300 μm wide region of the FAZ (FD-300), and parafoveal vessel density in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were calculated using novel built-in software with PAR. Results. There was no statistically significant difference in the FAZ area (). There was a statistically significant difference in the FAZ perimeter () and the AI () between the four groups. There was a correlation between the AI and the increasing severity of DR (). Statistically significant decreases of vessel density in the FD-300, SCP, and DCP were observed (all ). There was a difference in parafoveal vessel density in the DCP between the healthy control eyes and the eyes with diabetes without DR (). There was a significant correlation between vessel density and increasing severity of DR (). Conclusion. Compared with the FAZ area, AI allows a more helpful quantitative assessment of the changes in the FAZ. Vessel density determined using OCTA with PAR might be a useful parameter indicating the progression of DR. Parafoveal vessel density in the DCP after PAR might be a potential early biomarker of DR before appearance of clinically evident retinopathy and needs further investigation.

1. Introduction

Diabetic retinopathy (DR) is a major microvascular complication of diabetes and is a leading cause of acquired blindness in the population of working age worldwide [1, 2]. Chronic hyperglycemia leads to increased inflammation, hypoxia, and oxidative stress, all of which leads to changes in the microvessels of the retina [3]. Detection of these changes at the microvascular level during the different stages of DR is an area of increasing research interest that should provide important information regarding the perfusion status of the retina and the likelihood of developing more severe retinopathy. Dilated slit-lamp examination and fluorescein angiography of the fundus are the methods most commonly used to detect DR [4, 5]. However, these tests have limited ability to detect microvascular changes.

Optical coherence tomography angiography (OCTA) is a safe, rapid, and noninvasive technique for visualization of the retinal and choroidal microvessels with a resolution exceeding that of fundus fluorescein angiography (FFA) [69]. OCTA can show and quantify the superficial and deep vascular plexuses, impaired capillary perfusion, and neovascularization with high resolution [1013]. OCTA also provides information on the dimensions and shape of the foveal avascular zone (FAZ), changes in which are most likely related to macular ischemia, especially in DR [1417]. Enlargement of the FAZ area in DR has been reported [15, 1820]; however, some studies did not detect differences in the FAZ area between eyes with diabetes without DR and control eyes without diabetes [21, 22]. There seems to be high variability in the FAZ area. A more helpful quantitative marker needs to be identified. Other studies have demonstrated the ability of OCTA to distinguish healthy eyes from eyes with varying levels of DR severity [13, 17, 23, 24], but these studies are limited by projection artifacts during visualization of the deeper retinal vascular structures. Projection artifacts can result in false measurements of vessel density and the FAZ borders in the deep capillary plexus (DCP) [2426]. Accurate assessment of capillary nonperfusion in the retinal plexuses may be useful when monitoring diabetic retinopathy.

The aim of this study was to assess the characteristics of foveal microvascular abnormalities in different stages of DR using the recently developed AngioAnalytics software (version 2017.1.0.151) with projection artifacts removal (PAR) technology and new FAZ parameters. We studied several OCTA-based vascular parameters, including FAZ measurements and retinal vessel density. We compared the findings between patient groups, that is, controls, eyes with diabetes mellitus (DM) without DR, eyes with mild to moderate nonproliferative DR (NPDR), and eyes with the severe NPDR or proliferative DR (PDR).

2. Materials and Methods

This cross-sectional observational study was performed at the First Affiliated Hospital of Anhui Medical University, followed the tenets of the Helsinki and was approved by the Institutional Review Board of the First Affiliated Hospital of Anhui Medical University.

2.1. Participants

Ninety-three eyes of 59 patients with DM were examined. Eyes from patients with DM without DR and eyes with DR based on clinical assessment by retinal specialists were eligible for inclusion in the study. The exclusion criteria were glaucoma, uveitis, a high refractive error (more than 6 diopters), other retinal diseases, and cataract graded above nuclear opalescence. A healthy control group consisting of 31 eyes of 24 age-matched subjects without DM was also included. Each subject underwent comprehensive ocular examinations, including measurement of best-corrected visual acuity (BCVA), biomicroscopy examination of the fundus, color fundus photography, measurement of intraocular pressure, and OCTA. DR grades were based on the Early Treatment Diabetic Retinopathy Study classification endorsed in 2003 by the American Academy of Ophthalmology Guidelines Committee [27]. The eyes of the patients with diabetes were divided into three groups on the basis of their DR grades as determined by fundus photography and examinations as follows: a DM without DR (no DR) group, a mild to moderate NPDR (mild DR) group, and a severe NPDR to PDR (severe DR) group. BCVA was converted to the logMAR as described previously [28]. Eyes that had OCTA images with a scan quality index (SQI) less than 6 were excluded.

2.2. Angiographic Imaging

An AngioVue OCTA device (Optovue, Inc., CA, USA) was used to obtain the angiography images [29]. This instrument performs 70,000 A-scans per second and acquires OCTA volumes consisting of 304 ∗ 304 A-scans over an area of 3 × 3 mm2. We obtained 3 × 3 mm2 sections centered on the fovea. The foveal thickness and SQI of each image were recorded. Foveal retinal thickness (FRT) was defined as the average retinal thickness within the central 1 mm diameter ring (Figure 1(a)).

We used the newly developed built-in AngioAnalytics software (version 2017.1.0.151) to obtain measurements for a series of parameters in the foveal area [29]. This software is an updated version that includes two important advances, that is, the PAR algorithm and improved FAZ parameters.

The FAZ was defined as the area encompassing the central fovea where there are no vessels. In the quantitative analysis of the FAZ, the area was evaluated as in previous studies but with the introduction of two additional parameters, that is, the perimeter and the acircularity index (AI) (Figure 1(b)). The device automatically outlines the boundary of the FAZ along the centermost capillaries, allowing the area and perimeter of this zone to be calculated. The AI is measured using the following equation: AI = perimeter calculated/standard circular perimeter of equal area. The AI becomes larger as the shape becomes less smooth or less round.

The proprietary three-dimensional PAR algorithm developed by Optovue removes projection artifacts from the entire OCTA volume on a per voxel basis, using information from the OCT and OCTA volume to differentiate the OCTA signal in situ from projection artifacts [29]. We obtained the vessel density of the full retina in a width of 300 μm around the FAZ (FD-300) (Figure 1(b)) and the parafoveal vessel density for the superficial capillary plexus (SCP) (Figure 1(c)) and DCP (Figure 1(d)) using the built-in three-dimensional PAR software. The “parafovea” is defined as an annulus centered on the fovea with inner and outer ring diameters of 1 mm and 3 mm, respectively. Vessel density is a measurement of the proportion of pixels occupied by flowing vessels of the total pixels within the area of analysis (Figure 1(c), 1(d)). Error in automatic segmentation sometimes occurred; in these cases, we manually corrected the entire scan volume. The above parameters were used to assess impairment of ocular perfusion in the macular area.

2.3. Statistical Analysis

The data were assessed for normality using the Shapiro–Wilk test. All data are presented as the mean ± standard deviation (SD), median and interquartile range (IQR, 25th-75th percentile), or percentages as appropriate. Differences between the categorical data were assessed using the chi-square test or Fisher’s exact test. Differences in the data obtained were assessed using Student’s t-test, analysis of variance (ANOVA), or the Wilcoxon rank test, depending on their distribution. Since not all variances of the groups are equal, the nonparametric Kruskal–Wallis test with Bonferroni correction for multiple comparisons was used to compare values between groups. The Kendall tau correlation coefficient was used to examine correlations between the OCTA parameters and severity of DR. All the statistical analyses were performed using SPSS for Windows version 21.0 software (IBM Corp., Armonk, NY, USA). All statistical tests were considered significant when the value was <0.05.

3. Results

3.1. Participant Demographics and Clinical Characteristics

One hundred twenty-four eyes of 83 subjects were included (31 eyes of 24 control subjects and 93 eyes of 59 patients with diabetes). The patient demographics, clinical characteristics, and SQI are reported in Table 1.


ControlNo DRMild DRSevere DR value

Patients, 24172121
Eyes, 31313428
Sex0.151
Female, (%)19 (79.2)14 (82.4)12 (57.1)12 (57.1)
Male, (%)5 (20.8)3 (17.6)9 (42.9)9 (42.9)
Age, y, mean ± SD53.2 ± 8.5356.3 ± 8.2153.2 ± 9.9450.4 ± 7.510.226
Disease duration, y, mean ± SD6 (1–7)10 (7–20)10 (8.5–15)0.001
BCVA, logMAR, mean ± SD0 (0–0.1)0 (0–0.1)0.1 (0.0–0.2)0.4 (0.2–0.7)<0.001
FRT, µm, mean ± SD248.0 ± 17.53248.0 ± 14.54246.3 ± 30.11309.1 ± 120.440.001
SQI, mean ± SD7.26 ± 0.687.00 ± 0.687.06 ± 0.696.82 ± 0.820.141

3.2. Analysis of the FAZ

The first column in Figure 2 shows a representative sample of FAZ measurements with increasing DR severity. In the no DR group, the FAZ deviated from the gently undulating perimeter seen in the healthy controls. Breaks in the border, increased tortuosity, vessel loops, and budding of tortuous capillaries into the FAZ were also observed as the DR progressed. The average FAZ area, perimeter, and AI for the full retina in each study group (control, no DR, mild DR, and severe DR) are shown in Table 2. There was no statistically significant difference in the FAZ area between the four study groups (Table 2). Statistically significant differences in the FAZ perimeter and AI were observed between the four groups (). When post hoc multiple comparisons were performed, statistically significant increases in the FAZ perimeter (Table 2, Figure 3(b)) and AI (Table 2, Figure 3(c)) were observed in severe DR group when compared with the control group. When post hoc multiple comparisons were performed, statistically significant increases in the AI were observed in mild DR group when compared with the control group (Table 2, Figure 3(c)).


Control No DR Mild DR Severe DR F/H value value

FAZ area, mm2, mean ± SD0.28 ± 0.080.33 ± 0.080.33 ± 0.150.35 ± 0.135.1350.162a
FAZ, perimeter, mm, mean ± SD2.10 ± 0.322.34 ± 0.322.33 ± 0.582.52 ± 0.5411.2770.010b
AI, mean ± SD1.13 ± 0.031.16 ± 0.051.18 ± 0.071.22 ± 0.1026.794<0.001c

aMultiple comparisons are tested using the Kruskal–Wallis test; bmultiple comparisons are tested using the Kruskal–Wallis test, severe DR > control (, after Bonferroni correction); cmultiple comparisons are tested using the Kruskal–Wallis test, mild DR > control (, after Bonferroni correction) and severe DR > control (, after Bonferroni correction).
3.3. Analysis of Foveal Microcirculation Parameters

Figure 2 shows a representative sample of vessel density in the FD-300 (the first column) and parafoveal vessel density in the SCP (the second column) and DCP (the fourth column) with increasing severity of DR. Color maps were also used to show the changes in vessel density in the SCP (the third column) and DCP (the fifth column). Table 3 shows the foveal microcirculation parameters in the FD-300, SCP, and DCP for each group. Statistically significant decreases in vessel density were observed in the FD-300, SCP, and DCP (Table 3). When post hoc multiple comparisons were performed, vessel density in the FD-300 and SCP was significantly higher in the control group than in the mild DR and severe DR groups (Figure 3(d) and 3(e)). Vessel density in the FD-300 and SCP was significantly higher in the no DR group than in the mild DR and severe DR groups (Figures 3(d) and 3(e)). Vessel density in the FD-300 and SCP was significantly higher in the mild DR group than in the severe DR group (Figures 3(d) and 3(e)). The vessel density in the DCP was significantly higher in the control group than in the other three groups (Figure 3(f)). Vessel density in the DCP was significantly higher in the no DR and mild DR groups than in the severe DR group (Figure 3(f)). Vessel density in the DCP was significantly higher in the mild DR group than in the severe DR group (Figure 3(f)).


Control No DR Mild DR Severe DR F/H value value

Vessel density
 FD-300, %, mean ± SD49.82 ± 3.5548.21 ± 3.9345.33 ± 4.1241.87 ± 4.6721.683<0.001d
Parafoveal vessel density
 SCP, %, mean ± SD49.47 ± 3.4147.56 ± 4.0842.57 ± 4.9438.26 ± 5.5258.526<0.001e
 DCP, %, mean ± SD52.85 ± 3.2250.26 ± 4.5448.58 ± 4.3441.86 ± 5.9330.643<0.001f

dMultiple comparisons are tested using one-way ANOVA with a post hoc test, control > mild DR (), control > severe DR (), no DR > mild DR (), no DR > severe DR (), and mild DR > severe DR (); emultiple comparisons are tested using the Kruskal–Wallis test, no DR > severe DR (, after Bonferroni correction), control > severe DR (, after Bonferroni correction), no DR > mild DR (, after Bonferroni correction), mild DR > severe DR (, after Bonferroni correction), and control > mild DR (, after Bonferroni correction); fmultiple comparisons are tested using one-way ANOVA with a post hoc test, control > no DR (), control > mild DR (), control > severe DR (), no DR > severe DR (), and mild DR > severe DR ().
3.4. Correlations between OCTA Parameters and Severity of DR

In Kendall tau correlation coefficient analysis, we observed significant correlations between severity of DR and vessel density in the FD-300, SCP, and DCP () (Table 4). Retinal vessel density measured in the FD-300, SCP, and DCP decreased significantly with increasing severity of DR. The AI also showed a significant trend of increase with increasing severity of DR () (Table 4).


No DR Mild DR Severe DR Correlation coefficient value

FAZ area, mm2, mean ± SD0.33 ± 0.080.33 ± 0.150.35 ± 0.130.0170.832
FAZ, perimeter, mm, mean ± SD2.34 ± 0.322.33 ± 0.582.52 ± 0.540.0910.260
AI, mean ± SD1.16 ± 0.051.18 ± 0.071.22 ± 0.100.2130.010
Vessel density
 FD-300, %, mean ± SD48.21 ± 3.9345.33 ± 4.1241.87 ± 4.67−0.384<0.001
Parafoveal vessel density
 SCP, %, mean ± SD47.56 ± 4.0842.57 ± 4.9438.26 ± 5.52−0.490<0.001
 DCP, %, mean ± SD50.26 ± 4.5448.58 ± 4.3441.86 ± 5.93−0.441<0.001

4. Discussion

In this study, we quantified and analyzed the foveal microvascular abnormalities in different stages of DR using OCTA. Previous studies have reported the changes in the capillaries of the macular area using conventional fundus photography and FFA and suggested that the foveal microvascular abnormalities might be useful when evaluating the progression of DR [4, 5, 30]. However, conventional fundus photography had limited image resolution and FFA has potentially serious side effects because of injection of fluorescent dye. New technologies have been evaluated as an alternative to FFA, and OCTA, which is rapid to perform and noninvasive, has shown the greatest potential in this field [1417,31]. Good reproducibility and repeatability of FAZ measurements in both healthy eyes and eyes with retinal diseases have been reported recently [32]. Furthermore, no statistically significant difference in FAZ perimeter, AI, or vessel density was found between measurements [33]. These results, together with the easy operation of the device, short acquisition time, and avoidance of potentially phototoxic blue light, suggest that OCTA holds promise as a tool for monitoring ocular pathology and detecting early disease [34].

In this study, we used AngioAnalytics software that improves and streamlines the interpretation of OCTA data by removing projection artifacts from the entire OCTA volume and introduces new FAZ parameters for analysis.

Previous studies have shown enlargement of the FAZ area in eyes with DR [15,2527]. However, another study did not show a difference in the FAZ area between patients with DM without DR and nondiabetic controls [21]. FFA did not identify significant enlargement of the FAZ but found significant enlargement of the parafoveal intercapillary area in the SCP [22]. Our results showed no significant change in the FAZ area during progression of DR. This could be related to the high variability of the FAZ area. There is considerable variation in the FAZ area between normal individuals and patients with diabetes [3537]. There was a significant overlap between the healthy and diseased groups, which limited the sensitivity and specificity of the FAZ area for identifying and staging disease [3537]. The quantitative difference in the FAZ area did not correspond to morphologic changes in the regularity and appearance of the FAZ in the concomitant qualitative analysis [38].

Numerous qualitative studies have demonstrated that FAZ becomes more acircular in DR, with greater effects on the perimeter than on the area [19,39,40]. However, few studies have attempted to quantify the irregularity of the FAZ and correlate this metric to the stages of DR. In our study, we found that the FAZ in DR deviated from the gently undulating perimeter found in healthy controls and became apparent in eyes with serious disease. Breaks in the border, increased tortuosity, vessel loops, and budding of tortuous capillaries into the FAZ were also observed and were similar to the findings in previous qualitative studies [39]. On further quantitative evaluation, we found statistically significant trends with increasing severity of DR. AI may be more useful for monitoring of DR than the FAZ area.

Our next finding was that vessel density showed a strong correlation with the severity of DR, which is consistent with previous studies [23]. The FD-300 was the area that corresponded to the juxtafoveal region where capillary loss has been described in previous studies in patients without DR [18, 20], but was not observed in our study population. Nesper et al. [23] reported finding no difference in vessel density (SCP or DCP) between healthy control eyes and the eyes of patients with DM without DR. Interestingly, we observed a significant difference in vessel density only at the DCP but not at the SCP when comparing the eyes of healthy controls with those of patients with DM without DR. This may be explained by projection artifacts. Projection artifacts, which come from fluctuating shadows cast by blood cells flowing in the more superficial vessels, affect visualization of the deeper retinal vascular structures [4143]. These projection artifacts can be picked up by most OCTA technologies as false flow and cause superficial vascular networks to be duplicated on deeper slabs on en face angiograms. Projection artifact can give false impressions of the density of vessels, especially in evaluation of the DCP [2426,41]. With PAR, projection artifacts can be removed from the normally avascular outer retinal slab while preserving the density and continuity of the intermediate and deep retinal capillary plexuses [25, 29]. In this study, as a result of advances in OCTA software, we were able to perform a more refined analysis of the DCP because of the removal of projection artifacts. The FD-300 was the vessel density of the full retina, not only the SCP or DCP in a 300 μm around the FAZ.

It is important to note that in this study, vessel density in the DCP decreased significantly in the eyes of patients with DM without DR. This metric measured by OCTA with PAR may help identify vascular changes before the onset of funduscopically visible disease. This is a finding that deserves further study as a potential early biomarker of DR before clinically evident retinopathy.

The potential limitations of this study are its cross-sectional design and evaluation of FAZ area, which may vary consistently even in normal individuals. A prospective and longitudinal study is needed in the future. Another limitation may be the automated preset algorithm in the AngioVue system that only segments two retinal capillary plexuses, that is, the SCP and DCP. Some studies have suggested that the SCP, middle capillary plexus (MCP), and DCP show different areas of nonperfusion in eyes with DR [44, 45]. Therefore, the SCP, MCP, and DCP should be assessed quantitatively in future studies. The strength of our study was the PAR in evaluation of the DCP. Segmentation errors and decreased SQI may impact the automatically generated vessel density and FAZ metrics. To avoid this problem, we manually corrected the entire scan volume and excluded eyes that had OCTA images with an SQI less than 6. No significant differences in SQI were found between the four groups.

5. Conclusions

This study introduces AI as a marker of changes in the FAZ and shows that it may be a more helpful imaging biomarker than FAZ area for monitoring the progression of DR. We found a significant correlation between vessel density and disease severity in eyes with DR. Furthermore, the parafoveal vessel density in the DCP determined by OCT with PAR may serve as an early indicator for subclinical stages of DR and needs further investigation.

Data Availability

Researchers can access the data supporting the conclusions of this study through the authors. Lun Liu (liulundoc@126.com) and Jian Gao (shuijinglovegj@126.com) can be contacted to request the data.

Conflicts of Interest

The authors have no conflicts of interest.

Acknowledgments

This research was supported by grants from the Major Program of the Social Science Foundation of Anhui Province, China (SK2014ZD037).

References

  1. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at: Publisher Site | Google Scholar
  2. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at: Publisher Site | Google Scholar
  3. D. A. Antonetti, R. Klein, and T. W. Gardner, “Diabetic retinopathy,” New England Journal of Medicine, vol. 366, no. 13, pp. 1227–1239, 2012. View at: Publisher Site | Google Scholar
  4. Diabetic Retinopathy Study Research Group, “A modification of the Airlie House classification of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 21, no. 1, pp. 210–226, 1981. View at: Google Scholar
  5. M. Ivanisevic and R. Stanic, “Importance of fluorescein angiography in the early detection and therapy of diabetic retinopathy,” Ophthalmologica, vol. 201, no. 1, pp. 9–13, 1990. View at: Publisher Site | Google Scholar
  6. R. F. Spaide, J. M. Klancnik, and M. J. Cooney, “Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography,” JAMA Ophthalmology, vol. 133, no. 1, pp. 45–50, 2015. View at: Publisher Site | Google Scholar
  7. J. Lee and R. Rosen, “Optical coherence tomography angiography in diabetes,” Current Diabetes Reports, vol. 16, no. 12, p. 123, 2016. View at: Publisher Site | Google Scholar
  8. R. F. Spaide, J. G. Fujimoto, and N. K. Waheed, “Optical coherence tomography angiography,” Retina, vol. 35, no. 11, pp. 2161-2162, 2015. View at: Publisher Site | Google Scholar
  9. M. Zhang, J. Wang, A. D. Pechauer et al., “Advanced image processing for optical coherence tomographic angiography of macular diseases,” Biomedical Optics Express, vol. 6, no. 12, p. 4661, 2015. View at: Publisher Site | Google Scholar
  10. F. Scarinci, P. L. Nesper, and A. A. Fawzi, “Deep retinal capillary nonperfusion is associated with photoreceptor disruption in diabetic macular ischemia,” American Journal of Ophthalmology, vol. 174, pp. 179-180, 2016. View at: Google Scholar
  11. A. Shahlaee, M Perkianaki, J. Hsu et al., “Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography,” American Journal of Ophthalmology, vol. 165, no. 9, pp. 50–55, 2016. View at: Publisher Site | Google Scholar
  12. Y. Jia, S. T. Bailey, D. J. Wilson et al., “Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration,” Ophthalmology, vol. 121, no. 7, pp. 1435–1444, 2014. View at: Publisher Site | Google Scholar
  13. A. Y. Kim, Z. Chu, A. Shahidzadeh et al., “Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography,” Investigative Ophthalmology and Visual Science, vol. 57, no. 9, pp. 362–370, 2016. View at: Publisher Site | Google Scholar
  14. A. Ishibazawa, T. Nagaoka, A. Takahashi et al., “Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study,” American Journal of Ophthalmology, vol. 160, no. 1, pp. 35–44, 2015. View at: Publisher Site | Google Scholar
  15. F. J. Freiberg, M. Pfau, J. Wons et al., “Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 254, no. 6, pp. 1051–1058, 2016. View at: Publisher Site | Google Scholar
  16. P. D. Bradley, D. A. Sim, P. A. Keane et al., “The evaluation of diabetic macular ischemia using optical coherence tomography angiography,” Investigative Ophthalmology and Visual Science, vol. 57, no. 2, pp. 626–631, 2016. View at: Publisher Site | Google Scholar
  17. T. S. Hwang, S. S. Gao, L. Liu et al., “Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy,” JAMA Ophthalmology, vol. 134, no. 4, pp. 367–373, 2016. View at: Publisher Site | Google Scholar
  18. T. E. de Carlo, A. T. Chin, M. A. Bonini Filho et al., “Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography,” Retina, vol. 35, no. 11, pp. 2364–2370, 2015. View at: Publisher Site | Google Scholar
  19. J. Conrath, R. Giorgi, D. Raccah et al., “Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment,” Eye, vol. 19, no. 3, pp. 322–326, 2005. View at: Publisher Site | Google Scholar
  20. N. Takase, M. Nozaki, A. Kato et al., “Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography,” Retina, vol. 35, no. 11, pp. 2377–2383, 2015. View at: Publisher Site | Google Scholar
  21. M. M. Goudot, A. Sikorav, O. Semoun et al., “Parafoveal OCT angiography features in diabetic patients without clinical diabetic retinopathy: a qualitative and quantitative analysis,” Journal of Ophthalmology, vol. 2017, no. 9, p. 8676091, 2017. View at: Publisher Site | Google Scholar
  22. O. Arend, S. Wolf, F. Jung et al., “Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network,” British Journal of Ophthalmology, vol. 75, no. 9, pp. 514–518, 1991. View at: Publisher Site | Google Scholar
  23. P. L. Nesper, P. K. Roberts, A. C. Onishi et al., “Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography,” Investigative Ophthalmology and Visual Science, vol. 58, no. 6, pp. 307–315, 2017. View at: Publisher Site | Google Scholar
  24. H. Lee, M. Lee, H. Chung et al., “Quantification of retinal vessel tortuosity in diabetic retinopathy using optical coherence tomography angiography,” Retina, vol. 38, no. 5, pp. 1–10, 2018. View at: Publisher Site | Google Scholar
  25. D. Huang, D. J. Wilson, J. P. Campbell et al., “Projection-resolved optical coherence tomographic angiography,” Biomedical Optics Express, vol. 7, no. 3, pp. 816–828, 2016. View at: Google Scholar
  26. D. Huang, D. Li, L. Liu et al., “Automated choroidal neovascularization detection algorithm for optical coherence tomography angiography,” Biomedical Optics Express, vol. 6, no. 9, pp. 3564–3576, 2015. View at: Google Scholar
  27. C. P. Wilkinson, R. E. Klein, P. P. Lee et al., “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales,” Opthalmology, vol. 110, no. 9, pp. 1677–1682, 2003. View at: Publisher Site | Google Scholar
  28. J. T. Holladay, “Proper method for calculating average visual acuity,” Journal of Refractive Surgery, vol. 13, no. 4, pp. 388–391, 1997. View at: Google Scholar
  29. S. T. Garrity, N. A. Iafe, N. Phasukkijwatana et al., “Quantitative analysis of three distinct retinal capillary plexuses in healthy eyes using optical coherence tomography angiography,” Investigative Ophthalmology and Visual Science, vol. 58, no. 12, pp. 5548–5555, 2017. View at: Publisher Site | Google Scholar
  30. C. L. Lobo, R. C. Bernardes, and J. G. Cunha-Vaz, “Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes,” Archives of Ophthalmology, vol. 118, no. 10, pp. 1364–1369, 2000. View at: Publisher Site | Google Scholar
  31. M. Zhang, T. S. Hwang, C. Dongye et al., “Automated quantification of nonperfusion in three retinal plexuses using projection-resolved optical coherence tomography angiography in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 57, no. 13, pp. 5101–5106, 2016. View at: Publisher Site | Google Scholar
  32. Q. You, W. R. Freeman, R. N. Weinreb et al., “Reproducibility of vessel density measurement with optical coherence tomography angiography in eyes with and without retinopathy,” Retina, vol. 37, no. 8, pp. 1475–1482, 2017. View at: Publisher Site | Google Scholar
  33. S. Mo, B. Krawitz, E Efstathiadis et al., “Imaging foveal microvasculature: optical coherence tomography angiography versus adaptive optics scanning light ophthalmoscope fluorescein angiography,” Investigative Ophthalmology and Visual Science, vol. 57, no. 9, pp. 130–140, 2016. View at: Publisher Site | Google Scholar
  34. Y. Yang, J. Wang, H. Jiang et al., “Retinal microvasculature alteration in high myopia,” Investigative Ophthalmology and Visual Science, vol. 57, no. 14, pp. 6020–6030, 2016. View at: Publisher Site | Google Scholar
  35. A. M. Dubis, B. R. Hansen, R. F. Cooper et al., “Relationship between the foveal avascular zone and foveal pit morphology,” Investigative Ophthalmology and Visual Science, vol. 53, no. 3, pp. 1628–1636, 2012. View at: Publisher Site | Google Scholar
  36. J. Tam, J. A. Martin, and A. Roorda, “Noninvasive visualization and analysis of parafoveal capillaries in humans,” Investigative Ophthalmology and Visual Science, vol. 51, no. 3, pp. 1691–1698, 2010. View at: Publisher Site | Google Scholar
  37. G. Hilmantel, R. A. Applegate, W. A. van Heuven et al., “Entoptic foveal avascular zone measurement and diabetic retinopathy,” Optometry and Vision Science Official Publication of the American Academy of Optometry, vol. 76, no. 12, pp. 826–831, 1999. View at: Publisher Site | Google Scholar
  38. G. Di, Y. Weihong, Z. Xiao et al., “A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 254, no. 5, pp. 873–879, 2016. View at: Publisher Site | Google Scholar
  39. S. H. Alipour, H. Rabbani, M. Akhlaghi et al., “Analysis of foveal avascular zone for grading of diabetic retinopathy severity based on curvelet transform,” Graefes Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 11, pp. 1607–1614, 2012. View at: Publisher Site | Google Scholar
  40. G. H. Bresnick, R. Condit, S. Syrjala et al., “Abnormalities of the foveal avascular zone in diabetic retinopathy,” Archives of Ophthalmology, vol. 102, no. 9, pp. 1286–1293, 1984. View at: Publisher Site | Google Scholar
  41. R. F. Spaide, J. G. Fujimoto, and N. K. Waheed, “Image artifacts in optical coherence tomography angiography,” Retina, vol. 35, pp. 2163–2180, 2015. View at: Publisher Site | Google Scholar
  42. G. E. Lang, C. Enders, M. Loidl et al., “Accurate OCT-angiography interpretation-detection and exclusion of artifacts,” Klin Monbl Augenheilkd, vol. 234, no. 9, pp. 1109–1118, 2017. View at: Publisher Site | Google Scholar
  43. R. N. Louzada, T. E. de Carlo, M. Adhi et al., “Optical coherence tomography angiography artifacts in retinal pigment epithelial detachment,” Canadian Journal of Ophthalmology, vol. 52, no. 4, pp. 419–424, 2017. View at: Publisher Site | Google Scholar
  44. J. J. Park, B. T. Soetikno, and A. A. Fawzi, “Characterization of the middle capillary plexus using optical coherence tomography angiography in healthy and diabetic eyes,” Retina, vol. 36, no. 11, pp. 2039–2050, 2016. View at: Publisher Site | Google Scholar
  45. T. S. Hwang, M. Zhang, K. Bhavsar et al., “Visualization of 3 distinct retinal plexuses by projection-resolved optical coherence tomography angiography in diabetic retinopathy,” JAMA Ophthalmology, vol. 134, no. 12, pp. 1411–1419, 2016. View at: Publisher Site | Google Scholar

Copyright © 2018 Lun Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1107 Views | 411 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.